摘要:
A new compound, 3'-fluoro-3'-deoxykanamycin A is now provided, which is active against gram-negative and gram-positive bacteria, including kanamycin-resistant strains of bacteria and is useful as antibacterial agent for therapeutic treatment of bacterial infections. This new compound is produced by a process comprising reacting a 6- azido-2,4-di-O-protected-3,6-dideoxy-3-fluoro-α-D-glucopyranosyl bromide with the 4-hydroxyl group of a 6-0-(2'-0- protected-3'-N-protected-3'-amino-4',6'-di-O-protected-3'-deoxy-a-D-glucopyranosyl)-1,3-bis-N-protected-2-deoxystreptamine, reducing the azido group of the resulting reaction product into an amino group, and removing the remaining protective groups from the reduction product.
摘要:
1-N-(L-3-amino-2-hydroxypropionyl)-2',3'-dideoxykanamycin A and 1-N-(L-4-amino-2-hydroxybutyryl)-2',3'- dideoxykanamycin A are now provided which each is a new compound useful as antibacterial agent. The new compounds each is produced by acylating the 1-amino group of 2',3'-dideoxykanamycin A with L-3-amino-2-hydroxypropionic or L-4-amino-2-hydroxybutyric acid.
摘要:
New compounds, 2',3'-dideoxy-2'-fluorokanamycin A and 1-N-(a-hydroxy-w-aminoalkanoyl) derivatives thereof, particularly 1-N-(DL- or L-3-amino-2-hydroxypropionyl)- and 1-N-(L-4-amino-2-hydroxybutyryt)-2',3'-dideoxy-2'-fluorokanamycins A are now provided, which are each useful as anti-bacterial agent. 2',3'-Dideoxy-2'-fluorokanamycin A is prepared by a process comprising condensing a 6-azido-4-0-protected-2,3-6-trideoxy-2-fluoro-a-D-ribo-hexopyranosyl bromide with the 4-hydroxyl group of a 6-0-(2',4',6'-tri-0- protected-3'-N-protected-3'-amino-3'-deoxy-α-D-glucopyranosyl)-1,3-bis-N-protected-2-deoxystreptamine, reducing the resulting condensation product to convert its azido group into an amino group, and removing the remaining amino-protecting and hydroxyl-protecting groups from the reduction product.
摘要:
New antibiotic designated MF266 substance is now obtained from fermentaton of a new microorganism Streptomyces MF266-g4 (desposited under FERM-P 5401 or ATCC 31910). This new substance is useful as antibacterial agent and/or an antitumor agent for the inhibition of experimental animal tumors.
摘要:
A new process is provided for the production of a di-alkyl 3-aminoglutarate which are found useful as intermediates for the synthesis of β-lactam antibiotics of carbapenem type such as thienamycin. The new process comprises reacting an ammonium salt or ammonia with a di-alkyl ester of 3- ketoglutaric acid to form unsaturated amine compounds and reducing the latter with an alkali metal cyanoborohydride. The N-protected derivative of di-alkyl 3-aminoglutarate prepared may be converted into the optically active p-(S)-mono-alkyl half ester by treatment with esterase to hydrolyze only one of the esters (pro-R ester), followed by conventional N-deprotection. Further, di-alkyl 3-aminoglutarate itself may immediately be converted into the optically active β-(R)-mono-alkyl half ester of 3-aminoglutaric acid by treatment with esterase to hydrolyze preferentially one ester-forming alkyl group (pro-S ester).
摘要:
5"-N-alkoxycarbonyl and 5"-N-aralkyloxycarbonyl derivatives of caprazene, said caprazene being the compound represented by the following formula (I)
摘要:
Caprazol-3"'-ester derivatives of the formula (VII) wherein Me is methyl group, R 4 is a straight chain or a substantially straight chain alkyl group of 5-21 carbon atoms or a straight chain or a substantially straight chain alkenyl group of 5-21 carbon atoms or an alkynyl group of 5-21 carbon atoms and R 5 is hydrogen atom or an alkyl group of 1-21 carbon atoms, or a pharmaceutically acceptable acid addition salt thereof. The novel caprazol derivatives now synthesized exhibit excellent antibacterial activities against a variety of bacteria including acid-fast bacteria.
摘要:
Provided is a process for producing an isocoumarin-3-yl-acetic acid derivative, characterized by reacting a homophthalic acid derivative represented by formula (a): (wherein Rc, R2 and R are mainly protecting groups) with a malonic acid derivating represented by formula (IV): (wherein R is an organic group including a lower alkyl group; R3 is a protecting group for a carboxyl group; and X is a halogen atom or a -OM group (wherein M is alkaline metal or alkaline earth metal)). According to the above process, various isocoumarin-3-yl-acetic acid derivatives can efficiently be provided.